The Mount Sinai Addiction Psychiatry Fellowship

This one-year, ACGME-accredited fellowship with an optional, second research year, takes place at The Mount Sinai Roosevelt Hospital in Manhattan and at Mount Sinai’s affiliated Bronx Veterans Affairs Medical Center.

Fellows participate in the diagnosis and treatment of all substance use and co-occurring disorders in specialized inpatient and outpatient settings, and develop expertise in pharmacologic treatment using buprenorphine, methadone, naltrexone, acamprosate, disulfiram, and other biological treatment options. Fellows also gain experience in the psychotherapies of addictive disorders, including group therapy, motivational interviewing and consultation-liaison addiction activities.

Supervision is provided by Board Certified Addiction Psychiatrists, Addiction Medicine Attending Physicians, and Psychologists who dedicate their time entirely to the addiction field. The fellowship program offers trainees an opportunity to concentrate on a particular area that matches their particular interest.

Mount Sinai’s addiction psychiatry fellowship provides opportunities to teach and supervise psychiatry residents and medical students, and assume a leadership role in multidisciplinary teams. Didactic education in biological, psychological, and social theories of addiction is an integral part of the program, as are other academic activities such as grand rounds and journal club.

The optional second year of the fellowship offers in-depth participation in research activities in addiction psychiatry as well as the opportunity to work with internationally renowned basic scientists and clinical researchers focused on addictions. A broad range of research opportunities is available, including basic science and neuroimaging, as well as human laboratory and treatment outcomes research. Altogether, these opportunities provide an integrated approach to clinical and research training.

Candidates must complete an ACGME-accredited psychiatry residency prior to entering this fellowship program.  A valid New York State medical license and individual DEA number are also required.  A buprenorphine waiver, while not required, is preferable.

Applications are accepted beginning in May and interviews are usually conducted August thru October.


Contact Us

Faye Chao, MD
Associate Program Director, Mount Sinai
Fellowship in Addiction Psychiatry
Unit Chief, Inpatient Addiction Service
Mount Sinai Roosevelt Hospital
1000 Tenth Avenue
New York, NY 10019
Tel: 212-523-6308
Fax: 212-523-8057

Rossyovi Mercedes
Education Coordinator
Fellowship in Addiction Psychiatry
Department of Psychiatry
Mount Sinai St. Luke's Hospital
1090 Amsterdam Avenue, 16th Fl
New York, NY 10025
T: 212-523-5194
F: 212-523-3642

Richard N. Rosenthal, MD
Program Director, Mount Sinai
Fellowship in Addiction Psychiatry
Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
Medical Director of Addiction Psychiatry
Mount Sinai Behavioral Health System
425 West 59th St., Suite 7C
New York, NY 10019
Tel: 212-523-5366
Fax: 212-523-7720